Hepatoprotection via the IL-6/Stat3 pathway

被引:191
|
作者
Taub, R [1 ]
机构
[1] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
关键词
D O I
10.1172/JCI20031200319974
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Stat3 is a vital transcription factor that is activated downstream of the gp130 receptor, primarily via IL-6 signaling in adult liver. A new study (see the related article beginning on page 989) demonstrates that Stat3 provides hepatoprotection against Fas-mediated apoptotic liver damage by two mechanisms: direct inactivation of caspases and reduction of reactive oxygen species.
引用
收藏
页码:978 / 980
页数:3
相关论文
共 50 条
  • [41] The Role of MRE11 in the IL-6/STAT3 Pathway of Lung Cancer Cells
    Wu, Ching-Yuan
    Shu, Li-Hsin
    Liu, Hung-Te
    Cheng, Yu-Ching
    Wu, Yu-Huei
    Wu, Yu-Heng
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (12) : 6132 - 6144
  • [42] Analysis of the IL-6/STAT3 signalling pathway and DNA methylation patterns in patients with IBD
    Ali, Raja Affendi Raja
    Hartnett, Lori
    Geeleher, Paul
    Seoighe, Cathal
    Golden, Aaron
    Egan, Laurence
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 146 - 146
  • [43] Study on expression of IL-6/JAK/STAT3 signaling pathway in category IIIB prostatitis
    Li, Guangyu
    Lan, Haiyan
    Liang, Jihong
    Xian, Jing
    Fang, Dan
    Mo, Yuncong
    Zheng, Cheng
    Dong, Yingjin
    Li, Yuanfa
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 3779 - 3785
  • [44] Effect of carvacrol on IL-6/STAT3 pathway after partial hepatectomy in rat liver
    Ozen, Durmus B.
    Uyanoglu, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2018, 119 (09): : 593 - 601
  • [45] Small Molecule Inhibitors of IL-6/STAT3 Signaling
    Ye Jiqing
    Yue Xiaohong
    Sun Liping
    PROGRESS IN CHEMISTRY, 2016, 28 (07) : 1099 - 1111
  • [46] GLUCOSYLCERAMIDE INHIBIT IL-6/STAT3 SIGNALING PATHWAY AND LEADS TO AN IMPAIRMENT OF LIVER REGENERATION
    Gretchen, I.
    Sandhoff, R.
    Gonzalez-Carmona, M.
    Weber, S.
    Buettner, R.
    Lammert, F.
    Sauerbruch, T.
    Yildiz, Y.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S363 - S364
  • [47] STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor
    Wang, Yuxin
    van Boxel-Dezaire, Anette H. H.
    Cheon, HyeonJoo
    Yang, Jinbo
    Stark, George R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (42) : 16975 - 16980
  • [48] Inhibition of Sphingolipid Pathway Affects Cholesterol Gallstone Formation in Mice by the Modulation of IL-6/STAT3 Pathway
    Lim, Eun-Hye
    Kim, Jae Seon
    Lee, Beom Jae
    Jeong, Yoon A.
    Park, Jong-Jae
    Lee, Joon Young
    Jung, Wonho
    Lim, Sang-ah
    Lee, Sehe Dong
    Bak, Young-Tae
    GASTROENTEROLOGY, 2012, 142 (05) : S606 - S606
  • [49] Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells
    Cao, Wei
    Liu, Ying
    Zhang, Ran
    Zhang, Bo
    Wang, Teng
    Zhu, Xianbing
    Mei, Lin
    Chen, Hongbo
    Zhang, Hongling
    Ming, Pinghong
    Huang, Laiqiang
    SCIENTIFIC REPORTS, 2015, 5
  • [50] Kukoamine A alleviates nephrolithiasis by inhibiting endogenous oxalate synthesis via the IL-6/JAK/STAT3/DAO signaling pathway
    Ju, Yingjie
    Du, Mengwei
    Wang, Zhongyi
    Mu, Xin
    Miao, Yaodong
    Guo, Zhimou
    Wang, Dekun
    Wang, Shiyao
    Ding, Junjie
    Jin, Gaowa
    Zhang, Wen
    Qiao, Huanhuan
    Su, Yanfang
    Liu, Xiuyun
    Yuchi, Zhiguang
    Tan, Xiaoyue
    Wang, Yiwen
    PHYTOMEDICINE, 2024, 135